Recelltis
NDC 71929-070
Product Information
Recelltis is a OTC MONOGRAPH FINAL-approved product labeled by Cellnovation Technology. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 71929-070 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 71929-070?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LIDOCAINE (UNII: 98PI200987)
- LIDOCAINE (UNII: 98PI200987) (Active Moiety)
- POLYMYXIN B SULFATE (UNII: 19371312D4)
- POLYMYXIN B (UNII: J2VZ07J96K) (Active Moiety)
- BACITRACIN ZINC (UNII: 89Y4M234ES)
- BACITRACIN (UNII: 58H6RWO52I) (Active Moiety)
- NEOMYCIN SULFATE (UNII: 057Y626693)
- NEOMYCIN (UNII: I16QD7X297) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILVER (UNII: 3M4G523W1G)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 2001994 - bacitracin zinc 400 UNT / lidocaine HCl 20 MG / neomycin 3.5 MG / polymyxin B 5,000 UNT per GM Topical Cream
- RxCUI: 2001994 - bacitracin zinc 0.4 UNT/ML / lidocaine hydrochloride 0.02 MG/ML / neomycin 0.0035 MG/ML / polymyxin B 5 UNT/ML Topical Cream
* Please review the full disclaimer at the bottom of this page.